1. Andrographolide suppresses non-small-cell lung cancer progression through induction of autophagy and antitumor immune response. (May 2022) Authors: Wang, Xuan-Run; Jiang, Ze-Bo; Xu, Cong; Meng, Wei-Yu; Liu, Pei; Zhang, Yi-Zhong; Xie, Chun; Xu, Jing-Yi; Xie, Ya-Jia; Liang, Tu-Liang; Yan, Hao-Xin; Fan, Xing-Xing; Yao, Xiao-Jun; Wu, Qi-Biao; Leung, Elaine Lai-Han Journal: Pharmacological research Issue: Volume 179(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Chelidonine selectively inhibits the growth of gefitinib-resistant non-small cell lung cancer cells through the EGFR-AMPK pathway. (September 2020) Authors: Xie, Ya-Jia; Gao, Wei-Na; Wu, Qi-Biao; Yao, Xiao-Jun; Jiang, Ze-Bo; Wang, Yu-Wei; Wang, Wen-Jun; Li, Wei; Hussain, Shahid; Liu, Liang; Leung, Elaine Lai-Han; Fan, Xing-Xing Journal: Pharmacological research Issue: Volume 159(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Current Clinical Progress of PD-1/PD-L1 Immunotherapy and Potential Combination Treatment in Non–Small Cell Lung Cancer. (December 2019) Authors: Li, Jia-Xin; Huang, Ju-Min; Jiang, Ze-Bo; Li, Run-Ze; Sun, Ao; Lai-Han Leung, Elaine; Yan, Pei-Yu Journal: Integrative cancer therapies Issue: Volume 18(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Dolutegravir derivative inhibits proliferation and induces apoptosis of non-small cell lung cancer cells via calcium signaling pathway. (November 2020) Authors: Wang, Wen-Jun; Mao, Long-Fei; Lai, Huan-Ling; Wang, Yu-Wei; Jiang, Ze-Bo; Li, Wei; Huang, Ju-Min; Xie, Ya-Jia; Xu, Cong; Liu, Pei; Li, Yue-Ming; Leung, Elaine Lai Han; Yao, Xiao-Jun Journal: Pharmacological research Issue: Volume 161(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer. (1st September 2021) Authors: Jiang, Ze-Bo; Wang, Wen-Jun; Xu, Cong; Xie, Ya-Jia; Wang, Xuan-Run; Zhang, Yi-Zhong; Huang, Ju-Min; Huang, Min; Xie, Chun; Liu, Pei; Fan, Xing-Xing; Ma, Yu-Po; Yan, Pei-Yu; Liu, Liang; Yao, Xiao-Jun; Wu, Qi-Biao; Lai-Han Leung, Elaine Journal: Cancer letters Issue: Volume 515(2021) Page Start: 36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Metabolomics and integrated network pharmacology analysis reveal Tricin as the active anti-cancer component of Weijing decoction by suppression of PRKCA and sphingolipid signaling. (September 2021) Authors: Li, Jia-Xin; Li, Run-Ze; Sun, Ao; Zhou, Hua; Neher, Erwin; Yang, Jia-Shun; Huang, Ju-Min; Zhang, Yi-Zhong; Jiang, Ze-Bo; Liang, Tu-Liang; Ma, Lin-Rui; Wang, Jian; Wang, Xuan-Run; Fan, Xiao-Qing; Huang, Jie; Xie, Ying; Liu, Liang; Tang, Ling; Leung, Elaine Lai-Han; Yan, Pei-Yu Journal: Pharmacological research Issue: Volume 171(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Plumbagin suppresses non-small cell lung cancer progression through downregulating ARF1 and by elevating CD8+ T cells. (July 2021) Authors: Jiang, Ze-Bo; Xu, Cong; Wang, Wenjun; Zhang, Yi-Zhong; Huang, Ju-Min; Xie, Ya-Jia; Wang, Qian-Qian; Fan, Xing-Xing; Yao, Xiao-Jun; Xie, Chun; Wang, Xuan-Run; Yan, Pei-Yu; Ma, Yu-Po; Wu, Qi-Biao; Leung, Elaine Lai-Han Journal: Pharmacological research Issue: Volume 169(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Roles of Serum Amyloid A 1 Protein Isoforms in Rheumatoid Arthritis. (March 2022) Authors: Leung, Elaine Laihan; Lai, Huan-Ling; Li, Run-Ze; Pan, Hu-Dan; Jiang, Ze-Bo; Li, Ying; Duan, Fu-Gang; Xu, Jia-Hui; Zhang, Yi-Zhong; Shi, A-Xi; Wei, Chun-Li; Zhang, Fang-Yuan; Yao, Xiao-Jun; Liu, Liang Journal: Engineering Issue: Volume 10(2022) Page Start: 174 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Shikonin inhibits gefitinib-resistant non-small cell lung cancer by inhibiting TrxR and activating the EGFR proteasomal degradation pathway. (January 2017) Authors: Li, Xia; Fan, Xing-Xing; Jiang, Ze-Bo; Loo, Wings TY; Yao, Xiao-Jun; Leung, Elaine Lai-Han; Chow, Louis WC; Liu, Liang Journal: Pharmacological research Issue: Volume 115(2017:Jan.) Page Start: 45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Β-Elemene enhances erlotinib sensitivity through induction of ferroptosis by upregulating lncRNA H19 in EGFR-mutant non-small cell lung cancer. (May 2023) Authors: Xu, Cong; Jiang, Ze-Bo; Shao, Le; Zhao, Zi-Ming; Fan, Xing-Xing; Sui, Xinbing; Yu, Li-Li; Wang, Xuan-Run; Zhang, Ruo-Nan; Wang, Wen-Jun; Xie, Ya-Jia; Zhang, Yi-Zhong; Nie, Xiao-Wen; Xie, Chun; Huang, Ju-Min; Wang, Jing; Wang, Jue; Leung, Elaine Lai-Han; Wu, Qi-Biao Journal: Pharmacological research Issue: Volume 191(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗